|
LOC651250 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.263800E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.676400E-02 |
| Normal-vs-Stage2 |
3.339900E-02 |
| Normal-vs-Stage3 |
1.378940E-04 |
| Normal-vs-Stage4 |
1.508500E-02 |
| Stage1-vs-Stage2 |
6.400400E-01 |
| Stage1-vs-Stage3 |
2.084200E-02 |
| Stage1-vs-Stage4 |
5.503400E-01 |
| Stage2-vs-Stage3 |
2.327800E-01 |
| Stage2-vs-Stage4 |
9.267600E-01 |
| Stage3-vs-Stage4 |
2.421800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.442500E-03 |
| Normal-vs-AfricanAmerican |
1.395630E-01 |
| Normal-vs-Asian |
3.409000E-01 |
| Caucasian-vs-AfricanAmerican |
7.204800E-01 |
| Caucasian-vs-Asian |
1.442630E-01 |
| AfricanAmerican-vs-Asian |
5.127200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.284500E-03 |
| Normal-vs-Female |
8.515300E-03 |
| Male-vs-Female |
7.257800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.045630E-01 |
| Normal-vs-Age(41-60Yrs) |
1.257250E-03 |
| Normal-vs-Age(61-80Yrs) |
1.657450E-03 |
| Normal-vs-Age(81-100Yrs) |
1.142040E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.651600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.823700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.249560E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.461600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.083800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.429200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.395300E-04 |
| Classical-VS-Follicular |
7.55340000000437E-05 |
| Classical-VS-Other |
1.176370E-01 |
| Classical-VS-Normal |
1.395160E-01 |
| Tall-VS-Follicular |
9.148600E-01 |
| Tall-VS-Other |
8.184000E-01 |
| Tall-VS-Normal |
3.228400E-04 |
| Follicular-VS-Other |
7.988600E-01 |
| Follicular-VS-Normal |
3.81839999999967E-05 |
| Other-VS-Normal |
2.920200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.338400E-03 |
| Normal-vs-N1 |
4.663900E-02 |
| N0-vs-N1 |
6.107000E-01 |
|
|
